Duncan Campbell Investments Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1999-11-15 and was issued with the 090552293 ACN. Its Australian Business Number is 44090552293. Since 2020-07-29, the company is headquartered in NSW, post code 2119. The previous headquarters were located in NSW 2119 (from 2015-03-19 to 2020-07-29), NSW 2119 (from 2014-09-17 to 2015-03-19), and NSW 2119 (from 2012-05-07 to 2014-09-17). Duncan Campbell Investments Pty Ltd was registered for the GST on 2022-06-01, up until 2022-08-16. The above data comes from the ABN database which was updated on 2022-11-24.
| Status | From | To |
|---|---|---|
| Cancelled | 2022-08-16 | current |
| Active | 2022-06-01 | 2022-08-16 |
| Cancelled | 2022-01-31 | 2022-06-01 |
| Active | 2000-06-17 | 2022-01-31 |
| Name | From | To |
|---|---|---|
| Duncan Campbell Investments Pty. Ltd. | 2002-05-05 | current |
| Duncan Campbell Investments Pty Ltd | 2000-06-17 | 2002-05-05 |
| Location | From | To |
|---|---|---|
| NSW 2119 | 2020-07-29 | current |
| NSW 2119 | 2015-03-19 | 2020-07-29 |
| NSW 2119 | 2014-09-17 | 2015-03-19 |
| NSW 2119 | 2012-05-07 | 2014-09-17 |
| NSW 2119 | 2000-06-17 | 2012-05-07 |
| Status | From | To |
|---|---|---|
| Registered | 2022-06-01 | 2022-08-16 |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61B 5/029 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | B - diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000) |
| Main group code: | 5 - measuring for diagnostic purposes (radiation diagnosis a61b0006000000; diagnosis by ultrasonic, sonic or infrasonic waves a61b0008000000); identification of persons |
| Subgroup code: | 29 - measuring blood output from the heart, e.g. minute volume |
IP Australia process information:
| Expiry date: | 2032-07-17 |
General information:
| Patent status: |
Accepted Found to have no further lawful grounds of objection by the examiner. For innovation patents, acceptance is automatic following payment of fees. |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | G01N 21/00 |
| Section code: | G - physics |
| Class code: | 1 - measuring; testing |
| Subclass code: | N - investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or micro-organisms c12m, c12q) |
| Main group code: | 21 - investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light (g01n0003000000-g01n0019000000; take precedence);; |
IP Australia process information:
| Expiry date: | 2033-04-15 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2023 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2023, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.